Risk-characterization framework for decision-making at the food and drug administration / Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Year of Publication:2011
Language:English
Online Access:
Physical Description:xiv, 192 p.
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01432nam a2200325Ia 4500
001 5003378782
003 MiAaPQ
005 20200520144314.0
006 m o d |
007 cr cn|||||||||
008 110314s2011 dcu sb 000 0 eng d
020 |z 9780309212809 
035 |a (MiAaPQ)5003378782 
035 |a (Au-PeEL)EBL3378782 
035 |a (CaPaEBR)ebr10478232 
035 |a (CaONFJC)MIL313516 
035 |a (OCoLC)923283476 
040 |a MiAaPQ  |c MiAaPQ  |d MiAaPQ 
050 4 |a RA445  |b .R57 2011 
245 0 0 |a Risk-characterization framework for decision-making at the food and drug administration  |h [electronic resource] /  |c Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II. 
260 |a Washington, DC :  |b National Academies Press,  |c 2011. 
300 |a xiv, 192 p. 
504 |a Includes bibliographical references. 
533 |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. 
610 1 0 |a United States.  |b Food and Drug Administration  |x Management. 
650 0 |a Public health  |z United States. 
655 4 |a Electronic books. 
710 2 |a National Research Council (U.S.).  |b Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II. 
710 2 |a ProQuest (Firm) 
856 4 0 |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378782  |z Click to View